111 Capital Purchases Shares of 4,660 The Cigna Group (NYSE:CI)

111 Capital bought a new position in shares of The Cigna Group (NYSE:CI - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,660 shares of the health services provider's stock, valued at approximately $1,287,000.

A number of other institutional investors have also recently bought and sold shares of CI. TCTC Holdings LLC purchased a new position in The Cigna Group in the 4th quarter worth about $25,000. Collier Financial acquired a new stake in The Cigna Group during the 4th quarter worth about $32,000. Putney Financial Group LLC acquired a new stake in The Cigna Group during the 4th quarter worth about $36,000. Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group during the 4th quarter worth about $37,000. Finally, Transce3nd LLC acquired a new stake in The Cigna Group during the 4th quarter worth about $38,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. UBS Group decreased their price objective on The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. Robert W. Baird decreased their price objective on The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Barclays raised their price objective on The Cigna Group from $339.00 to $382.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a report on Friday, January 31st. Finally, Cowen reiterated a "buy" rating on shares of The Cigna Group in a report on Monday, May 5th. Two analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $379.33.

The Cigna Group Stock Performance

CI traded up $4.00 on Friday, hitting $316.05. The company had a trading volume of 2,732,235 shares, compared to its average volume of 1,706,123. The company's fifty day moving average price is $324.83 and its 200 day moving average price is $309.58. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market cap of $84.43 billion, a price-to-earnings ratio of 25.82, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. The company had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The company's revenue for the quarter was up 14.4% on a year-over-year basis. During the same period in the previous year, the business posted $6.47 EPS. Equities analysts predict that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be given a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.91%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is currently 33.44%.

Insiders Place Their Bets

In other news, CEO David Cordani sold 26,527 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now directly owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock valued at $13,603,991 in the last three months. Company insiders own 0.70% of the company's stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.